Cetuximab inhibits the growth of mucinous ovarian carcinoma tumor cells lacking KRAS gene mutations

By                  

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1336-1340

Spandidos Publications

Access to resources Recommend Favorite

Novel mutations of the HRAS gene and absence of hotspot mutations of the BRAF genes in oral squamous cell carcinoma in a Greek population

By Koumaki Dimitra   Kostakis George   Koumaki Vasiliki   Papadogeorgakis Nikolaos   Makris Michael   Katoulis Alexandros   Kamakari Smaragda   Koutsodontis George   Perisanidis Christos   Lambadiari Vaia   Chrysomali Evanthia   Stavrianeas Nikolaos   Alexandridis Constantinos   Rigopoulos Dimitrios  

Oncology Reports, Vol. 27, Iss. 5, 2012-05 ,pp. : 1555-1560

Spandidos Publications

Access to resources Recommend Favorite

Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer

By                

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1219-1224

Spandidos Publications

Access to resources Recommend Favorite

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas

By              

Oncology Letters, Vol. 7, Iss. 6, 2014-01 ,pp. : 2019-2022

Spandidos Publications

Access to resources Recommend Favorite

Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 163-171

Bentham Science Publishers

Access to resources Recommend Favorite